Results for 'EGFL7'

Order:
  1.  9
    Notch: Implications of endogenous inhibitors for therapy.Ivan Dikic & Mirko Hh Schmidt - 2010 - Bioessays 32 (6):481-487.
    Soluble components of Notch signalling can be applied to manipulate a central pathway essential for the development of metazoans and often deregulated in illnesses such as stroke, cancer or cardiovascular diseases. Commonly, the Notch cascade is inhibited by small compound inhibitors, which either block the proteolysis of Notch receptors by γ‐secretases or interfere with the transcriptional activity of the Notch intracellular domain. Specific antibodies can also be used to inhibit ligand‐induced activation of Notch receptors. Alternatively, naturally occurring endogenous inhibitors of (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  2.  16
    Cellular and molecular mechanisms underlying blood vessel lumen formation.Marta S. Charpentier & Frank L. Conlon - 2014 - Bioessays 36 (3):251-259.
    The establishment of a functional vascular system requires multiple complex steps throughout embryogenesis, from endothelial cell (EC) specification to vascular patterning into venous and arterial hierarchies. Following the initial assembly of ECs into a network of cord‐like structures, vascular expansion and remodeling occur rapidly through morphogenetic events including vessel sprouting, fusion, and pruning. In addition, vascular morphogenesis encompasses the process of lumen formation, critical for the transformation of cords into perfusable vascular tubes. Studies in mouse, zebrafish, frog, and human endothelial (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark